1. Home
  2. RUBI vs NEUP Comparison

RUBI vs NEUP Comparison

Compare RUBI & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RUBI
  • NEUP
  • Stock Information
  • Founded
  • RUBI N/A
  • NEUP 1996
  • Country
  • RUBI Marshall Islands
  • NEUP United States
  • Employees
  • RUBI N/A
  • NEUP N/A
  • Industry
  • RUBI Marine Transportation
  • NEUP
  • Sector
  • RUBI Consumer Discretionary
  • NEUP
  • Exchange
  • RUBI Nasdaq
  • NEUP Nasdaq
  • Market Cap
  • RUBI 8.9M
  • NEUP 10.3M
  • IPO Year
  • RUBI N/A
  • NEUP N/A
  • Fundamental
  • Price
  • RUBI $0.17
  • NEUP $4.75
  • Analyst Decision
  • RUBI
  • NEUP Strong Buy
  • Analyst Count
  • RUBI 0
  • NEUP 2
  • Target Price
  • RUBI N/A
  • NEUP $28.00
  • AVG Volume (30 Days)
  • RUBI 43.3M
  • NEUP 4.8M
  • Earning Date
  • RUBI 01-01-0001
  • NEUP 11-14-2025
  • Dividend Yield
  • RUBI N/A
  • NEUP N/A
  • EPS Growth
  • RUBI N/A
  • NEUP N/A
  • EPS
  • RUBI N/A
  • NEUP N/A
  • Revenue
  • RUBI $24,139,000.00
  • NEUP $15,649,448.00
  • Revenue This Year
  • RUBI N/A
  • NEUP N/A
  • Revenue Next Year
  • RUBI N/A
  • NEUP N/A
  • P/E Ratio
  • RUBI $0.10
  • NEUP N/A
  • Revenue Growth
  • RUBI N/A
  • NEUP N/A
  • 52 Week Low
  • RUBI $0.17
  • NEUP $2.90
  • 52 Week High
  • RUBI $6.69
  • NEUP $21.40
  • Technical
  • Relative Strength Index (RSI)
  • RUBI N/A
  • NEUP 36.71
  • Support Level
  • RUBI N/A
  • NEUP $4.36
  • Resistance Level
  • RUBI N/A
  • NEUP $5.18
  • Average True Range (ATR)
  • RUBI 0.00
  • NEUP 0.38
  • MACD
  • RUBI 0.00
  • NEUP 0.26
  • Stochastic Oscillator
  • RUBI 0.00
  • NEUP 65.60

About RUBI Rubico Inc. Common Stock

Rubico Inc operates as a holding company. It is an eco-conscious international crude oil shipping company. The company's primary business is the ownership and operation of an eco-conscious fleet of tanker vessels designed for enhanced fuel efficiency, reduced greenhouse emissions, and a wide range of environmentally friendly technologies.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: